LT2890680T - N-(3-fluorbenzil-2-(5-(4-morfolinofenil)piridin-2-il)acetamidas, kaip proteintirozinkinazės moduliatorius - Google Patents
N-(3-fluorbenzil-2-(5-(4-morfolinofenil)piridin-2-il)acetamidas, kaip proteintirozinkinazės moduliatoriusInfo
- Publication number
- LT2890680T LT2890680T LTEP13760222.3T LT13760222T LT2890680T LT 2890680 T LT2890680 T LT 2890680T LT 13760222 T LT13760222 T LT 13760222T LT 2890680 T LT2890680 T LT 2890680T
- Authority
- LT
- Lithuania
- Prior art keywords
- morpholinophenyl
- fluorobenzyl
- pyridin
- acetamide
- tyrosine kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261695100P | 2012-08-30 | 2012-08-30 | |
US201361779868P | 2013-03-13 | 2013-03-13 | |
PCT/US2013/057565 WO2014036426A1 (en) | 2012-08-30 | 2013-08-30 | N-(3-fluorobenzyl)-2-(5-(4-morpholinophenyl)pyridin-2-yl) acetamide as protein|tyrosine kinase modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
LT2890680T true LT2890680T (lt) | 2018-05-10 |
Family
ID=49162280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTEP13760222.3T LT2890680T (lt) | 2012-08-30 | 2013-08-30 | N-(3-fluorbenzil-2-(5-(4-morfolinofenil)piridin-2-il)acetamidas, kaip proteintirozinkinazės moduliatorius |
Country Status (13)
Country | Link |
---|---|
US (5) | US9926273B2 (lt) |
EP (1) | EP2890680B1 (lt) |
JP (3) | JP6499076B2 (lt) |
KR (1) | KR102346033B1 (lt) |
CN (2) | CN105263907B (lt) |
CA (1) | CA2883144C (lt) |
ES (1) | ES2664332T3 (lt) |
HK (2) | HK1212329A1 (lt) |
HU (1) | HUE037637T2 (lt) |
LT (1) | LT2890680T (lt) |
SI (1) | SI2890680T1 (lt) |
TW (1) | TWI664167B (lt) |
WO (1) | WO2014036426A1 (lt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7968574B2 (en) * | 2004-12-28 | 2011-06-28 | Kinex Pharmaceuticals, Llc | Biaryl compositions and methods for modulating a kinase cascade |
US7935697B2 (en) | 2006-12-28 | 2011-05-03 | Kinex Pharmaceuticals, Llc | Compositions for modulating a kinase cascade and methods of use thereof |
US9926273B2 (en) | 2012-08-30 | 2018-03-27 | Athenex, Inc. | Composition and methods for modulating a kinase cascade |
CN106902357B (zh) | 2015-12-21 | 2021-08-03 | 广州市香雪制药股份有限公司 | 药物组合物及其应用、药物包合物、静脉制剂及制备方法 |
CN106902358B (zh) * | 2015-12-21 | 2020-07-10 | 广州市香雪制药股份有限公司 | 口服制剂及其制备方法 |
CN114516832B (zh) * | 2020-11-20 | 2023-11-28 | 成都贝诺科成生物科技有限公司 | 一种微管蛋白抑制剂及其制备方法与应用 |
CN113354575B (zh) * | 2021-06-07 | 2022-09-27 | 河南应用技术职业学院 | 一种特班布林的合成方法 |
CN115477608B (zh) * | 2021-06-16 | 2023-12-12 | 成都贝诺科成生物科技有限公司 | 一种微管蛋白抑制剂及其制备方法与应用 |
CN116444425A (zh) * | 2022-01-14 | 2023-07-18 | 武汉人福创新药物研发中心有限公司 | 微管蛋白-src双靶点抑制剂 |
Family Cites Families (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1121922A (en) | 1966-06-17 | 1968-07-31 | Ici Ltd | Pyrimidine derivatives |
GB1147068A (en) | 1966-12-02 | 1969-04-02 | Ici Ltd | Phenyl-pyridine derivatives |
US3761477A (en) | 1968-11-08 | 1973-09-25 | Mc Neil Labor Inc | Pyrazineacetic acids, lower alkyl esters, amides and salts |
IT1044222B (it) | 1972-05-23 | 1980-03-20 | Zambeletti Spa L | Bifenilil alcanoilaminopiridine ad attivita anti infiammatoria di lunga durata |
AT341512B (de) | 1975-01-09 | 1978-02-10 | Thomae Gmbh Dr K | Verfahren zur herstellung von neuen biphenylathern |
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
CA1261835A (en) | 1984-08-20 | 1989-09-26 | Masaaki Toda | (fused) benz(thio)amides |
US4642903A (en) | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
JPS62252755A (ja) | 1986-04-11 | 1987-11-04 | Daikin Ind Ltd | 新規n−ベンジルベンズアミド誘導体およびこれを有効成分として含有する除草剤 |
US4855326A (en) | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
US5232948A (en) | 1990-09-10 | 1993-08-03 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity |
US5578322A (en) | 1990-11-30 | 1996-11-26 | Yamanouchi Pharmaceutical Co., Ltd. | Quick release coated preparation |
CH685875A5 (fr) | 1991-04-26 | 1995-10-31 | Pierre Baudet | Les N-phényl-benzamides protecteurs contre les effets nocifs de la lumière ultra-violette |
EP0613879A4 (en) | 1991-05-20 | 1995-05-03 | Tsumura & Co | PHELLODENDRIN ANALOGS AND TYPE IV ALLERGY SUPPRESSOR CONTAINING THEM AS ACTIVE INGREDIENTS. |
US5518730A (en) | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
US5380473A (en) | 1992-10-23 | 1995-01-10 | Fuisz Technologies Ltd. | Process for making shearform matrix |
DE4236103A1 (de) | 1992-10-26 | 1994-04-28 | Hoechst Ag | Verfahren zur Kreuzkupplung von aromatischen Boronsäuren mit aromatischen Halogenverbindungen oder Perfluoralkylsulfonaten |
US5643957A (en) | 1993-04-22 | 1997-07-01 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
FR2705671B1 (fr) | 1993-05-26 | 1995-07-07 | Inst Nat Sante Rech Med | Nouveaux dérivés de l'hydroxybiphényle, leur préparation et les compositions pharmaceutiques qui les contiennent. |
WO1995001782A2 (en) | 1993-07-09 | 1995-01-19 | R.P. Scherer Corporation | Method for making freeze dried drug dosage forms |
US5622719A (en) | 1993-09-10 | 1997-04-22 | Fuisz Technologies Ltd. | Process and apparatus for making rapidly dissolving dosage units and product therefrom |
US5895664A (en) | 1993-09-10 | 1999-04-20 | Fuisz Technologies Ltd. | Process for forming quickly dispersing comestible unit and product therefrom |
US5616344A (en) | 1994-06-14 | 1997-04-01 | Fuisz Technologies Ltd. | Apparatus and process for strengthening low density compression dosage units and product therefrom |
CA2144669A1 (en) | 1994-03-29 | 1995-09-30 | Kozo Akasaka | Biphenyl derivatives |
US5607697A (en) | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
FR2737721B1 (fr) | 1995-08-08 | 1997-09-05 | Roussel Uclaf | Nouveaux composes biphenyles, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicament et les compositions pharmaceutiques les contenant |
AU4885097A (en) | 1996-11-08 | 1998-06-03 | Sankyo Company Limited | Arylureas or arylmethylcarbamoyl derivatives |
ATE421318T1 (de) | 1997-02-20 | 2009-02-15 | Massachusetts Inst Technology | Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben |
ZA985542B (en) | 1997-07-03 | 1999-04-07 | Smithkline Beecham Corp | Substituted benzanilides as CCR5 receptor ligands antiinflammatory agents and antiviral agents |
AU9309898A (en) | 1997-09-09 | 1999-03-29 | Du Pont Pharmaceuticals Company | Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa |
US6277406B1 (en) | 1997-10-08 | 2001-08-21 | Fuisz Technologies Ltd. | Easily processed tablet compositions |
US7070936B1 (en) | 1999-01-13 | 2006-07-04 | The Research Foundation Of State University Of New York | Method for designing protein kinase inhibitors |
JP2001023259A (ja) | 1999-07-09 | 2001-01-26 | Sony Corp | 光磁気記録媒体およびその製造方法 |
WO2001019788A2 (en) | 1999-09-17 | 2001-03-22 | Cor Therapeutics, Inc. | BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
US6844367B1 (en) | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
US6372752B1 (en) | 2000-02-07 | 2002-04-16 | Genzyme Corporation | Inha inhibitors and methods of use thereof |
US20040039048A1 (en) | 2000-02-11 | 2004-02-26 | Manuel Guzman Pastor | Therapy with cannabinoid compounds for the treatment of brain tumors |
KR100423899B1 (ko) | 2000-05-10 | 2004-03-24 | 주식회사 엘지생명과학 | 세포 증식 억제제로 유용한 1,1-디옥소이소티아졸리딘을갖는 인다졸 |
US6900232B2 (en) | 2000-06-15 | 2005-05-31 | Pharmacia Corporation | Cycloalkyl alkanoic acids as integrin receptor antagonists |
US6376524B1 (en) | 2000-06-21 | 2002-04-23 | Sunesis Pharmaceuticals, Inc. | Triphenyl compounds as interleukin-4 antagonists |
JP2002020362A (ja) | 2000-07-06 | 2002-01-23 | Nippon Oruganon Kk | 新規ビフェニル誘導体 |
WO2002026696A1 (en) | 2000-09-29 | 2002-04-04 | Prolifix Limited | Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
CA2430037A1 (en) | 2000-11-20 | 2002-05-30 | Michael S. South | Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
EP1373257B9 (en) | 2001-03-29 | 2008-10-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
US7547716B2 (en) | 2001-06-08 | 2009-06-16 | Institute Of Medicinal Molecular Design, Inc. | Sulfonamide derivatives |
US6673829B2 (en) | 2001-09-14 | 2004-01-06 | Novo Nordisk A/S | Aminoazetidine,-pyrrolidine and -piperidine derivatives |
US20030186963A1 (en) | 2001-09-14 | 2003-10-02 | Dorwald Florencio Zaragoza | Substituted piperidines |
US7005445B2 (en) | 2001-10-22 | 2006-02-28 | The Research Foundation Of State University Of New York | Protein kinase and phosphatase inhibitors and methods for designing them |
DE10201764A1 (de) | 2002-01-18 | 2003-07-31 | Bayer Cropscience Ag | Substituierte 4-Aminopyridin-Derivate |
JP2003231633A (ja) | 2002-02-06 | 2003-08-19 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
CA2473505A1 (en) | 2002-02-07 | 2003-08-14 | Ellen M. Leahy | Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
FR2836917B1 (fr) | 2002-03-11 | 2006-02-24 | Lipha | Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant en tant que medicaments utilisables dans le traitement des pathologies caracterisees par une situation de stress oxydatif |
GB0206215D0 (en) | 2002-03-15 | 2002-05-01 | Novartis Ag | Organic compounds |
TWI319387B (en) | 2002-04-05 | 2010-01-11 | Astrazeneca Ab | Benzamide derivatives |
GB0209891D0 (en) | 2002-04-30 | 2002-06-05 | Glaxo Group Ltd | Novel compounds |
AU2003234464B2 (en) | 2002-05-03 | 2009-06-04 | Exelixis, Inc. | Protein kinase modulators and methods of use |
PE20040522A1 (es) | 2002-05-29 | 2004-09-28 | Novartis Ag | Derivados de diarilurea dependientes de la cinasa de proteina |
SE0201937D0 (sv) | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | Therapeutic agents |
AU2003254177A1 (en) | 2002-07-31 | 2004-02-16 | Smithkline Beecham Corporation | Substituted benzanilides as modulators of the ccr5 receptor |
AU2003250701A1 (en) | 2002-07-31 | 2004-02-16 | Wayne R. Danter | Protein tyrosine kinase inhibitors |
US20040242572A1 (en) | 2002-08-24 | 2004-12-02 | Boehringer Ingelheim International Gmbh | New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture |
DE10238865A1 (de) | 2002-08-24 | 2004-03-11 | Boehringer Ingelheim International Gmbh | Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
CA2506772A1 (en) | 2002-11-01 | 2004-05-21 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of jak and other protein kinases |
ATE343583T1 (de) | 2002-11-08 | 2006-11-15 | Novo Nordisk As | Halogensulfonylarylboronate |
ATE552253T1 (de) | 2002-11-08 | 2012-04-15 | Novartis Int Pharm Ltd | 3-substituierte-6-aryl- pyridin derivate als liganden für c5a-rezeptoren |
US8030336B2 (en) | 2002-12-13 | 2011-10-04 | Ym Biosciences Australia Pty Ltd | Nicotinamide-based kinase inhibitors |
CA2510471A1 (en) | 2002-12-19 | 2004-07-08 | Neurogen Corporation | Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators |
FR2850377B1 (fr) | 2003-01-23 | 2009-02-20 | Sanofi Synthelabo | Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique |
UY28213A1 (es) | 2003-02-28 | 2004-09-30 | Bayer Pharmaceuticals Corp | Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos. |
SG2009082793A (en) | 2003-06-03 | 2015-03-30 | Rib X Pharmaceuticals Inc | Biaryl heterocyclic compounds and methods of making and using the same |
EP2332912A1 (en) | 2003-08-08 | 2011-06-15 | Vertex Pharmaceuticals Incorporated | Heteroarylaminosulfonylphenylderivates for use as sodium or calcium channel blockers in the treatment of pain |
WO2005014532A1 (en) | 2003-08-08 | 2005-02-17 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions and methods of use |
FR2860514A1 (fr) | 2003-10-03 | 2005-04-08 | Sanofi Synthelabo | Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique |
US20050197364A1 (en) | 2003-10-07 | 2005-09-08 | Kelly Michael G. | Amide compounds as ion channel ligands and uses thereof |
EP2314576A1 (en) | 2003-11-05 | 2011-04-27 | F.Hoffmann-La Roche Ag | Phenyl derivatives as PPAR agonists |
DE602004027301D1 (de) | 2003-12-22 | 2010-07-01 | Merck Sharp & Dohme | Alpha-hydroxyamide als bradykininantagonisten oder inverse agonisten |
PE20060285A1 (es) | 2004-03-30 | 2006-05-08 | Aventis Pharma Inc | Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp) |
US8673889B2 (en) | 2004-04-26 | 2014-03-18 | Ono Pharmaceutical Co., Ltd. | BLT2-mediated disease, BLT2 binding agent and the compound |
JP2008503490A (ja) | 2004-06-17 | 2008-02-07 | センジェント・セラピューティクス・インコーポレイテッド | チロシンホスファターゼの三置換窒素調節物質 |
US7968574B2 (en) | 2004-12-28 | 2011-06-28 | Kinex Pharmaceuticals, Llc | Biaryl compositions and methods for modulating a kinase cascade |
PL1836169T3 (pl) | 2004-12-28 | 2012-07-31 | Kinex Pharmaceuticals Llc | Kompozycje i sposoby leczenia zaburzeń związanych z proliferacją komórek |
KR20080040027A (ko) | 2005-09-02 | 2008-05-07 | 아스테라스 세이야쿠 가부시키가이샤 | Rock 억제제로서 아미드 유도체 |
EP1983971A4 (en) | 2006-01-25 | 2010-11-24 | Synta Pharmaceuticals Corp | SUBSTITUTED AROMATIC COMPOUNDS FOR USE AGAINST INFLAMMATION AND IMMUNE DISORDERS |
WO2007095383A2 (en) | 2006-02-15 | 2007-08-23 | Myriad Genetics, Inc. | Prodrugs |
US20090076075A1 (en) * | 2006-03-02 | 2009-03-19 | Frederic Henri Jung | Quinoline derivatives |
WO2007099317A1 (en) * | 2006-03-02 | 2007-09-07 | Astrazeneca Ab | Quinazoline derivatives |
WO2007113565A1 (en) * | 2006-04-06 | 2007-10-11 | Astrazeneca Ab | Naphthyridine derivatives as anti-cancer agents |
CA2651732C (en) | 2006-05-18 | 2014-10-14 | Mannkind Corporation | Intracellular kinase inhibitors |
DK2041071T3 (da) | 2006-06-29 | 2014-09-01 | Kinex Pharmaceuticals Llc | Biarylsammensætninger og fremgangsmåder til modulering af en kinasekaskade |
CN101595084B (zh) | 2006-06-29 | 2013-01-02 | 金克斯医药品有限公司 | 用于调整激酶级联的二芳基组合物和方法 |
JP2009542673A (ja) | 2006-06-29 | 2009-12-03 | アリーナ ファーマシューティカルズ, インコーポレイテッド | ヒスタミンh3−受容体関連障害の治療に有用なヒスタミンh3−受容体モジュレータ |
NZ577111A (en) | 2006-12-15 | 2012-05-25 | Abbott Lab | Novel oxadiazole compounds |
US20100210649A1 (en) | 2006-12-21 | 2010-08-19 | Sloan-Kettering Institute For Cancer Research | Pyridazinones and furan-containing compounds |
TWI457336B (zh) | 2006-12-28 | 2014-10-21 | Kinex Pharmaceuticals Llc | 調節激酶級聯之組成物及方法 |
US7935697B2 (en) | 2006-12-28 | 2011-05-03 | Kinex Pharmaceuticals, Llc | Compositions for modulating a kinase cascade and methods of use thereof |
US7939529B2 (en) | 2007-05-17 | 2011-05-10 | Kinex Pharmaceuticals, Llc | Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof |
US20100256147A1 (en) | 2007-04-13 | 2010-10-07 | Hangauer Jr David G | Biaryl acetamide derivatives as modulators of the kinase cascade for the treatment of hearing loss, osteoporosis and cell proliferation disorders |
AU2008254500B2 (en) * | 2007-05-17 | 2014-01-23 | Atnx Spv, Llc | Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof |
WO2011129936A2 (en) * | 2010-04-16 | 2011-10-20 | Kinex Pharmaceuticals, Llc | Compositions and methods for the prevention and treatment of cancer |
US9926273B2 (en) | 2012-08-30 | 2018-03-27 | Athenex, Inc. | Composition and methods for modulating a kinase cascade |
-
2013
- 2013-08-30 US US14/015,030 patent/US9926273B2/en active Active
- 2013-08-30 ES ES13760222.3T patent/ES2664332T3/es active Active
- 2013-08-30 CA CA2883144A patent/CA2883144C/en active Active
- 2013-08-30 CN CN201380056173.9A patent/CN105263907B/zh active Active
- 2013-08-30 EP EP13760222.3A patent/EP2890680B1/en active Active
- 2013-08-30 TW TW102131239A patent/TWI664167B/zh active
- 2013-08-30 CN CN201811229699.3A patent/CN109999040A/zh active Pending
- 2013-08-30 SI SI201330972T patent/SI2890680T1/en unknown
- 2013-08-30 KR KR1020157008132A patent/KR102346033B1/ko active IP Right Grant
- 2013-08-30 WO PCT/US2013/057565 patent/WO2014036426A1/en active Application Filing
- 2013-08-30 HU HUE13760222A patent/HUE037637T2/hu unknown
- 2013-08-30 JP JP2015530099A patent/JP6499076B2/ja active Active
- 2013-08-30 LT LTEP13760222.3T patent/LT2890680T/lt unknown
-
2016
- 2016-01-06 HK HK16100079.6A patent/HK1212329A1/xx unknown
- 2016-03-29 HK HK16103558.0A patent/HK1215544A1/zh unknown
-
2018
- 2018-02-13 US US15/895,244 patent/US10106505B2/en active Active
- 2018-10-26 JP JP2018201398A patent/JP2019052153A/ja active Pending
-
2019
- 2019-05-10 US US16/408,780 patent/US20190263755A1/en not_active Abandoned
-
2020
- 2020-08-24 US US17/001,054 patent/US20210214305A1/en not_active Abandoned
- 2020-10-12 JP JP2020171651A patent/JP2021006580A/ja active Pending
-
2022
- 2022-09-29 US US17/955,712 patent/US20230167060A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20210214305A1 (en) | 2021-07-15 |
CN105263907A (zh) | 2016-01-20 |
HUE037637T2 (hu) | 2018-09-28 |
KR20150046329A (ko) | 2015-04-29 |
WO2014036426A1 (en) | 2014-03-06 |
KR102346033B1 (ko) | 2021-12-30 |
US20230167060A1 (en) | 2023-06-01 |
HK1215544A1 (zh) | 2016-09-02 |
US20180170875A1 (en) | 2018-06-21 |
CA2883144A1 (en) | 2014-03-06 |
US9926273B2 (en) | 2018-03-27 |
US20190263755A1 (en) | 2019-08-29 |
EP2890680B1 (en) | 2018-02-28 |
HK1212329A1 (en) | 2016-06-10 |
CN109999040A (zh) | 2019-07-12 |
TW201422585A (zh) | 2014-06-16 |
ES2664332T3 (es) | 2018-04-19 |
JP2021006580A (ja) | 2021-01-21 |
CA2883144C (en) | 2023-01-17 |
JP2015526526A (ja) | 2015-09-10 |
SI2890680T1 (en) | 2018-08-31 |
JP2019052153A (ja) | 2019-04-04 |
EP2890680A1 (en) | 2015-07-08 |
JP6499076B2 (ja) | 2019-04-10 |
TWI664167B (zh) | 2019-07-01 |
US10106505B2 (en) | 2018-10-23 |
US20140066445A1 (en) | 2014-03-06 |
CN105263907B (zh) | 2018-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LT2890680T (lt) | N-(3-fluorbenzil-2-(5-(4-morfolinofenil)piridin-2-il)acetamidas, kaip proteintirozinkinazės moduliatorius | |
HK1215577A1 (zh) | 蛋白激酶抑制劑 | |
HK1208459A1 (en) | Substituted pyrroles active as kinases inhibitors | |
HK1211297A1 (en) | Binding proteins comprising at least two repeat domains against her2 her2 | |
IL236495A0 (en) | Heteroaromatic compounds as proton tyrosine kinase inhibitors | |
EP2905290A4 (en) | HETERODIMER PROTEIN COMPOSITION | |
HK1198360A1 (en) | Heterocyclic protein kinase inhibitors | |
EP2833889A4 (en) | PROTEIN KINASE C HEMMER AND USES THEREOF | |
HRP20160744T1 (hr) | Heterocikličke tvari i njihova uporaba kao modulatora receptora tirozin kinaza tipa iii | |
EP3083559A4 (en) | Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors | |
EP2934525A4 (en) | THIAZOLSUBSTITUTED AMINOPYRIDINE AS MILTSTYROSINKINASE INHIBITOR | |
HK1209726A1 (en) | Protein kinase inhibitors | |
HK1205507A1 (en) | Protein kinase inhibitors | |
HK1210956A1 (en) | Heteroaromatic compounds as pi3 kinase modulators and methods of use pi3 | |
IL232333A (en) | N- (pyrid-4-ram) amides and n- (pyrimidin-4-ram) amides and their pharmacological and cosmetic uses | |
IL237158A0 (en) | Amino quinzolines as kinase inhibitors | |
HK1208460A1 (en) | Protein kinase inhibitors | |
EP2988744A4 (en) | THIAZOLE SUBSTITUTED AMINOHETEROARYL COMPOUNDS TYLOSINE KINASE SPLENIC INHIBITORS | |
EP2988749A4 (en) | Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors | |
EP2879679A4 (en) | ANTIBACTERIAL PROTEIN KINASE INHIBITORS | |
EP2976338A4 (en) | N- (2-CYANO-HETEROCYCLYL) PYRAZOLO-PYRIDONES AS INHIBITORS OF JANUS KINASE | |
EP3082807A4 (en) | Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors | |
EP3083560A4 (en) | Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors | |
ZA201508756B (en) | N-(2-fluoro-2-phenethyl)carboxamides as nematicides and endoparasiticides | |
GB201206048D0 (en) | Novel compounds and their use as kinase inhibitors |